Needham Reiterates Buy on Veracyte, Maintains $48 Price Target

Benzinga Newsdesk www.benzinga.com Neutral 91.9%

Neg 0% Neu 91.9% Pos 0%

Needham analyst Mike Matson reiterates Veracyte (NASDAQ:VCYT) with a Buy and maintains $48 price target.

Comments

No comments yet. Be the first!